🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Heartflow, Inc. HTFL R2K

Healthcare · Health Information Services · United States
https://www.heartflow.com

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in Mountain View, California.

READ MORE ›
$30.98
+3.30% 1Y

Market & Price

Market Cap
$2.67B
Current Price
$30.98
High / Low (52W)
$39.91 / $20.49
Beta
-

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
-
PEG Ratio
-
Book Value
$3.32
Price to Book
9.34
P/S
13.96
EV/EBITDA
-37.80
Dividend Yield
-

Profitability & Returns

ROCE
-32.07%
ROE
-135.31%
ROA
-16.22%
Profit Margin
-58.42%
Op Margin
-41.88%
EPS (Latest Qtr)
$-0.32
EPS (TTM)
$-3.09

Balance Sheet & Liquidity

Debt/Equity
0.09
Quick Ratio
5.10
Current Ratio
5.57
Debt
$26.35M
Total Assets
$359.45M
Current Assets
$220.20M
Working Capital
$177.83M

Ownership

Promoter Holding
5.16%
Chg in Prom Hold
-
FII / Inst Holding
77.85%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$2.54B
Total Revenue (TTM)
$191.42M
EBITDA
$-67.19M
Free Cash Flow
$-48.65M
Operating Cash Flow
$-70.96M
Shares Outstanding
86.24M
Gross Margin
78.06%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
42.10%
Profit 5Y
-11.05%
Revenue (YoY)
41.30%
Earnings (YoY)
-

PROS

  • Compounding revenue at 42.1% over 5 years.

CONS

  • Earnings shrank at -11.0% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 HTFL Heartflow, Inc. R2K 30.98 - $2.67B - -32.07% -135.31% 42.10% -11.05%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -31.05M--37.20M43.42M46.28M49.13M52.59M
Cost of Revenue ----9.26M10.65M10.86M10.07M10.42M
Gross Profit -23.84M--27.94M32.78M35.41M39.06M42.16M
Operating Expenses ----45.44M46.49M50.51M56.81M64.19M
Operating Income --14.18M---17.50M-13.71M-15.10M-17.75M-22.02M
EBITDA -----25.16M-373.00K-45.29M-22.31M-24.92M
Interest Expense ----5.09M6.62M3.45M8.00K3.00K
Pretax Income -----32.34M-9.14M-50.83M-24.56M-27.36M
Tax Provision ----059.00K30.00K-165.00K23.00K
Net Income -20.93M-23.38M---32.34M-9.20M-50.85M-24.39M-27.38M
Diluted EPS --4.66---0.40-0.11-1.04-0.29-0.32
R&D Expense -9.93M11.86M-13.92M15.03M17.30M-21.62M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2023Dec 2024Dec 2025
Revenue 87.17M125.81M176.03M
Cost of Revenue 29.12M31.36M40.84M
Gross Profit 58.05M94.45M135.20M
Operating Expenses 130.97M155.67M199.26M
Operating Income -72.91M-61.22M-64.07M
EBITDA -62.78M-65.51M-93.12M
Interest Expense 24.69M22.77M15.17M
Pretax Income -95.11M-96.37M-116.87M
Tax Provision 547.00K53.00K-76.00K
Net Income -95.66M-96.43M-116.79M
Diluted EPS -1.94-1.20-3.17
R&D Expense 35.85M43.52M64.92M

Compounded Sales Growth

5 Years:42.10%
1 Year:41.30%

Compounded Profit Growth

5 Years:-11.05%
1 Year:-

Stock Price Performance

1 Year:+3.30%
6 Months:-4.63%
3 Months:+33.77%
1 Month:+4.91%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -185.05M118.70M359.45M
Current Assets -148.45M82.29M220.20M
Cash & Equivalents -122.77M51.37M44.78M
Inventory ----
Receivables -20.55M24.64M29.34M
Total Liabilities -962.62M978.19M58.80M
Current Liabilities -32.81M33.60M42.37M
Long Term Debt -134.01M136.43M-
Total Debt -160.60M160.38M22.05M
Total Equity -693.64M-777.56M-859.48M300.65M
Shares Outstanding -80.62M80.62M85.28M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2023Dec 2024Dec 2025
Operating Cash Flow -76.43M-69.00M-54.02M
Investing Cash Flow -6.11M-4.36M-238.57M
Financing Cash Flow 169.32M2.24M286.04M
Capital Expenditure -6.11M-4.36M-5.03M
Free Cash Flow -82.54M-73.36M-59.05M
Net Change in Cash 86.78M-71.12M-6.55M
Share Buybacks 228.00K--

Ratios (Annual)

Figures in %.

Metric Dec 2023Dec 2024Dec 2025
Gross Margin % 66.6%75.1%76.8%
Operating Margin % -83.6%-48.7%-36.4%
Net Margin % -109.7%-76.6%-66.3%
ROE % 12.3%11.2%-38.8%
ROCE % -47.9%-71.9%-20.2%

Shareholding Pattern

Insiders
5.16%
Institutions
77.85%
Public Float
82.08%

Top Institutional Holders

#Holder% HeldSharesValue
1 Wellington Management Group, LLP 13.89% 11.98M $371.21M
2 Bain Capital Life Sciences Investors, LLC 12.12% 10.45M $323.68M
3 FMR, LLC 6.26% 5.40M $167.22M
4 BAMCO Inc. 4.44% 3.83M $118.58M
5 Janus Henderson Group PLC 2.53% 2.18M $67.57M
6 HealthCor Partners Management LP 2.41% 2.08M $64.50M
7 Vanguard Portfolio Management LLC 2.37% 2.05M $63.38M
8 Invesco Ltd. 2.22% 1.91M $59.27M
9 Vanguard Capital Management LLC 2.20% 1.89M $58.66M
10 Blackrock Inc. 1.70% 1.46M $45.31M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HTFL

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space